EP3976593 - MACROCYCLIC LIPIDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.05.2024 Database last updated on 24.08.2024 | |
Former | Examination is in progress Status updated on 30.06.2023 | ||
Former | Request for examination was made Status updated on 04.03.2022 | ||
Former | The international publication has been made Status updated on 05.12.2020 | ||
Former | unknown Status updated on 04.08.2020 | Most recent event Tooltip | 03.05.2024 | Application deemed to be withdrawn | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Translate Bio, Inc. 200 West Street Waltham, MA 02451 / US | [2022/25] |
Former [2022/14] | For all designated states Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 / US | Inventor(s) | 01 /
ZHANG, Yi C/o Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 / US | 02 /
KARVE, Shrirang C/o Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 / US | 03 /
DEROSA, Frank C/o Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 / US | 04 /
HEARTLEIN, Michael C/o Translate Bio, Inc. 29 Hartwell Avenue Lexington, MA 02421 / US | [2022/14] | Representative(s) | Lavoix 2, place d'Estienne d'Orves 75441 Paris Cedex 09 / FR | [N/P] |
Former [2022/14] | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | Application number, filing date | 20746395.1 | 29.05.2020 | [2022/14] | WO2020US35275 | Priority number, date | US201962855256P | 31.05.2019 Original published format: US 201962855256 P | [2022/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020243540 | Date: | 03.12.2020 | Language: | EN | [2020/49] | Type: | A1 Application with search report | No.: | EP3976593 | Date: | 06.04.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.12.2020 takes the place of the publication of the European patent application. | [2022/14] | Search report(s) | International search report - published on: | EP | 03.12.2020 | Classification | IPC: | C07D321/00, C07D323/00, C07D405/06, C07D493/10, C07C219/06, A61P43/00, A61K48/00 | [2022/14] | CPC: |
C07D321/00 (EP,US);
A61K9/1272 (US);
A61K38/177 (US);
A61K38/45 (US);
A61K39/385 (US);
A61K48/0033 (US);
A61P43/00 (EP);
C07C219/06 (EP);
C07C229/12 (US);
C07D323/00 (EP);
C07D405/06 (EP,US);
C07D405/14 (US);
C07D493/10 (EP);
C07D493/20 (US);
A61K2039/53 (US);
A61K2039/6018 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/14] | Title | German: | MAKROCYCLISCHE LIPIDE | [2022/14] | English: | MACROCYCLIC LIPIDS | [2022/14] | French: | LIPIDES MACROCYCLIQUES | [2022/14] | Entry into regional phase | 14.12.2021 | National basic fee paid | 14.12.2021 | Designation fee(s) paid | 14.12.2021 | Examination fee paid | Examination procedure | 14.12.2021 | Amendment by applicant (claims and/or description) | 14.12.2021 | Examination requested [2022/14] | 14.12.2021 | Date on which the examining division has become responsible | 03.07.2023 | Despatch of a communication from the examining division (Time limit: M06) | 16.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/23] | 06.02.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/23] | Fees paid | Renewal fee | 31.03.2022 | Renewal fee patent year 03 | 14.03.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2010042877 (TEKMIRA PHARMACEUTICALS CORP [CA], et al) [AD] 6-28 * Title; abstract; claims; exaamples. *; | [AD]WO2015184256 (SHIRE HUMAN GENETIC THERAPIES [US]) [AD] 6-28 * Title; abstract; claims; examples. *; | [AD]WO2017117528 (ACUITAS THERAPEUTICS INC [CA]) [AD] 6-28* Title; abstract; claims, examples 3-6. *; | [A]WO2017218524 (RANA THERAPEUTICS INC [US]) [A] 6-28 * Title; abstract; claims 1, 9-11. * | by applicant | WO2013149140 | WO2012170889 | US4373071 | US4401796 | US4415732 | US4458066 | US4500707 | US4668777 | US4897355 | US4973679 | US5047524 | US5132418 | US5153319 | US5171678 | US5262530 | US5334761 | US5700642 | US5744335 | US5780014 | US5885613 | WO2005121348 | WO2010042877 | WO2010053572 | WO2010144740 | US8093367 | US8304529 | WO2013063468 | WO2015095340 | WO2015184256 | WO2015199952 | WO2016004202 | US2016031928 | WO2016118725 | WO2016118724 | WO2016205691 | WO2017004143 | WO2017049245 | WO2017075531 | WO2017117528 | WO2017173054 | WO2018089801 | - S. M. BERGE et al., "pharmaceutically acceptable salts in detail", J. Pharmaceutical Sciences, (19770000), vol. 66, pages 1 - 19 | - JEMIELITY, J. et al., "Novel 'anti-reverse' cap analogs with superior translational properties", RNA, (20030000), vol. 9, doi:10.1261/rna.5430403, pages 1108 - 1122, XP002466761 DOI: http://dx.doi.org/10.1261/rna.5430403 | - JEMIELITY, J. et al., RNA, (20030000), vol. 9, pages 1108 - 1122 | - GRUDZIEN, E. et al., RNA, (20040000), vol. 10, pages 1479 - 1487 | - GRUDZIEN-NOGALSKA, E. et al., RNA, (20070000), vol. 13, pages 1745 - 1755 | - YOKOE, Nature Biotechnology, (19960000), vol. 14, pages 1252 - 1256 | - GAO et al., Biochem. Biophys. Res. Comm., (19910000), vol. 179, page 280 | - LASIC, Trends Biotechnol., (19980000), vol. 16, pages 307 - 321 | - J. MCCLELLANM. C. KING, Cell, (20100000), vol. 141, pages 210 - 217 | - WHITEHEAD et al., Nature Communications, (20140000), vol. 5, page 4277 | - FEIGNER et al., Proc. Nat'l Acad. Sci., (19870000), vol. 84, page 7413 | - BEHR et al., Proc. Nat.'1 Acad. Sci., (19890000), vol. 86, page 6982 | - SEMPLE et al., Nature Biotech., (20100000), vol. 28, pages 172 - 176 | - HEYES, J. et al., J Controlled Release, (20050000), vol. 107, pages 276 - 287 | - MORRISSEY, DV. et al., Nat. Biotechnol., (20050000), vol. 23, no. 8, pages 1003 - 1007 | - WOLF et al., BioTechniques, (19970000), vol. 23, page 139 | - KLIBANOV et al., FEBS Letters, (19900000), vol. 268, no. 1, pages 235 - 237 | - LUBKE et al., "Proteomics of the Lysosome", Biochim Biophys Acta, (20090000), vol. 1793, doi:10.1016/j.bbamcr.2008.09.018, pages 625 - 635, XP026073291 DOI: http://dx.doi.org/10.1016/j.bbamcr.2008.09.018 |